Dr. Gregory Wolf received his bachelor of science degree from the University of Notre Dame and completed medical school at the University of Michigan. He then went on to postgraduate training in otolaryngology and general surgery at the State University of New York, Upstate Medical Center in Syracuse, and Georgetown University. Dr. Wolf completed a two-year immunology fellowship at the National Institutes of Health and following that joined the faculty at the University of Michigan's Department of Otolaryngology-Head and Neck Surgery, where he served as department chair 1992-2008. Dr. Wolf's research interests include tumor immunology, immunotherapy and cell biology. His clinical trial research has included studies of immunotherapy and chemotherapy regimens. Dr. Wolf received national recognition as the leader of national trials that have provided the foundation for changing the standard therapy for patients with advanced laryngeal cancers.